Diseases of the hepatobiliary system: focus on rational hepatotropic therapy

Journal Title: Гастроентерологія - Year 2019, Vol 53, Issue 3

Abstract

The article presents data of the modern literature and our studies on the combined use of ursodeoxycholic acid and arginine glutamate in the pathology of the hepatobiliary system. Hepatobiliary diseases today remain a major socio-economic health problem worldwide, occupying a significant place in the structure of general somatic pathology in the clinic of internal medicine. Despite the apparent successes achieved over the past decades in the diagnosis and treatment of diseases of the hepatobiliary system, some issues are still not entirely resolved or there are contradictions about their treatment. It is known that not all hepatotropic drugs meet the requirements for active components that pathogenetically affect the links of pathological processes, which occur in the hepatobiliary tract. It is rather difficult to justify and systematize the treatment of hepatobiliary diseases with such a variety of causes of damage. The principles of modern therapy for most diseases of the hepatobiliary system include the administration of combinations of hepatotropic drugs. One of the most rational combinations of pharmacological agents for these purposes are preparations of ursodeoxycholic acid and arginine glutamate. These pharmacological agents are the drugs with the most substantial evidence base of clinical efficacy, significantly exceeding that of hepatotropic medications of other groups.

Authors and Affiliations

A. Yu. Filippova

Keywords

Related Articles

Pancreatic Diseases as One of the Main Problems in Gastroenterology and Abdominal Surgery (Modern Epidemiology)

The analysis of the data of Center for Medical Statistics of Ministry of Healthcare of Ukraine for 8 years (2006–2013) has been carried out. We have analyzed the parameters of prevalence, incidence and clinical cases of...

Glycyrrizinic acid: pathophysiological aspects of fibrosis formation and effectiveness in treatment of liver diseases

The review article presents current data on the causes of the onset and development of liver fibrosis. This condition is due to excessive accumulation of the extracellular matrix, the producer of which is mainly hepatic...

The Dynamics of Immunological Indicants on the Background of Therapy Using Probiotics and Psyllium in Patients with Chronic Pancreatitis after Cholecystectomy

The results of complex examination and treatment of 64 patients with chronic pancreatitis after cholecystectomy are given. It is ascertained, that complex therapy with the use of probiotics and psyllium in patients with...

Condition of the Colon and Upper Gastrointestinal Tract According to Data of Endoscopic Examination in Patients with Ulcerative Colitis and Crohn’s Disease with Anemic Syndrome

The paper studied the characteristics of endoscopic changes in colonic mucosa and upper gastrointestinal tract in patients with ulcerative colitis and Crohn’s disease with anemia. It is found that the development of anem...

Morphofunctional Changes in the Liver of Rats with Experimental Hepatitis in Nitric Oxide Imbalance

It was found that 7 days after four-time administration of carbon tetrachloride (CCl4), acute hepatitis develops in the liver of rats, the basis of it was predominantly common fatty degeneration which occupies 40–80 % of...

Download PDF file
  • EP ID EP668163
  • DOI 10.22141/2308-2097.53.3.2019.182866
  • Views 86
  • Downloads 0

How To Cite

A. Yu. Filippova (2019). Diseases of the hepatobiliary system: focus on rational hepatotropic therapy. Гастроентерологія, 53(3), 188-195. https://europub.co.uk./articles/-A-668163